SSB1122 creates the “Litigation Financing Transparency and Consumer Protection Act” and establishes a new regulatory framework for third-party litigation funding in Iowa. The bill defines litigation financing and litigation financing contracts, distinguishes them from ordinary contingency-fee arrangements, and requires any person engaging in litigation financing in the state to register with the secretary of state. Registration would require disclosure of identifying information about the financer and, for entities, information about significant owners and controllers. All registration filings would be public records.
The bill also imposes substantive limits on litigation financers’ conduct. It prohibits referral fees, commissions, and other kickbacks; bars financers from giving legal advice or influencing litigation decisions; caps the financer’s recovery at 25 percent of any judgment, award, settlement, verdict, or other monetary recovery; and prohibits interest above the rate allowed under Iowa’s usury laws. It requires detailed written contract disclosures, a five-business-day cancellation right, and notice to the consumer’s lawyer. It further requires disclosure of litigation financing contracts to opposing parties, the court, and certain insurers, and adds special notice requirements when the funding is directly or indirectly financed by a foreign person.
The bill reaches beyond consumer protection by addressing class actions, foreign funding, and enforcement. In class actions, it would apply to financed cases, impose a fiduciary duty on the litigation financer to class members, and require disclosure of relationships between class counsel and the financer. It also makes the financer jointly and severally liable for costs or monetary sanctions assessed against the consumer in the financed matter. Any violation of the chapter would make the contract unenforceable by the financer, and usury penalties could apply if the interest cap is exceeded. The secretary of state would be authorized to adopt rules to administer the chapter, and the act would take effect January 1, 2026, applying to pending or newly filed matters involving litigation financing on or after that date.
Overall sentiment in the bill materials appears supportive of regulation rather than outright prohibition. The bill is framed as a transparency and consumer-protection measure, suggesting concern about hidden terms, excessive returns, and outside influence over lawsuits. There is no recorded committee debate or vote history in the provided materials, so no direct opposition or support statements are available. The structure of the bill indicates a policy preference for allowing litigation financing to continue under strict disclosure, registration, and conduct rules.
The main points of contention likely concern the breadth of disclosure requirements, the 25 percent cap on recovery, the prohibition on foreign-entity financing, and the joint-and-several liability for costs and sanctions. Potentially affected parties include litigation finance companies, plaintiffs and their attorneys, insurers, class action participants, and entities that provide related services to consumers. The foreign-person and foreign-entity-of-concern provisions suggest an additional national-security or anti-foreign-influence concern that may be debated alongside consumer-protection issues.
The bill would add a new chapter to Iowa Code governing litigation financing, creating registration, disclosure, contract, and conduct requirements for litigation financers and related parties. It would also make litigation financing contracts subject to public filing, limit recoverable amounts and interest, restrict assignments and referral arrangements, and impose disclosure duties in ordinary and class-action litigation. Violations could render contracts unenforceable and trigger usury-related remedies, while the secretary of state would gain rulemaking authority to administer the new regulatory scheme.
The available materials suggest a generally favorable or at least cautious regulatory sentiment toward litigation financing. The bill is presented as a consumer-protection and transparency measure rather than a ban, indicating concern about abusive practices, hidden ownership, and outside control of lawsuits. Because there are no recorded committee transcripts or votes in the provided context, there is no documented floor or committee opposition to weigh against that framing.
The most likely areas of dispute are the bill’s strict limits on litigation financers, especially the 25 percent cap on recovery, the ban on influencing litigation strategy, and the requirement that financers be jointly and severally liable for costs and sanctions. Another likely point of contention is the broad disclosure regime, including public registration records and mandatory disclosure of financing contracts to opposing parties, courts, and insurers. The prohibition on funding that is directly or indirectly financed by a foreign entity of concern may also be controversial, particularly for firms with complex ownership structures or international capital sources.